1 unknown, 1 withdrawn. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 1, Withdrawn 1 |
| Phase 2 | 2 | Unknown 1, Withdrawn 1 |
Follow Infusion Pumps: new trials by email Literature Review of Infusion Pumps trials Research Report on Infusion Pumps
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dexmedetomidine Versus Nalbuphine in Prevention of Emergence Agitation Following Adenotonsillectomy in Pediatrics Dexmedetomidine, Nalbuphine, infusion pump - Emergence Delirium | Phase 1 / Phase 2 | Unknown | Ain Shams University | 120 | 2019-03-05 | 2019-08-20 |
| AUY922 With Lapatinib and Letrozole for ER+ HER2+ Advanced Breast Cancer AUY922 - Breast Cancer, Metastatic Breast Cancer | Phase 1 / Phase 2 | Withdrawn | Texas Tech University Health Sciences Center, El Paso | 2011-07-01 | 2017-05-09 |
Breast Neoplasms (1) · Emergence Delirium (1)
Ain Shams University (1) · Texas Tech University Health Sciences Center, El Paso (1)
Egypt (1)